PJT Partners Acts as Financial Adviser in Irish Continental Group Acquisition
PJT Partners is serving as the exclusive financial adviser to Irish Continental Group (ICG) regarding its acquisition by Bluefin Bidco Limited.
Stocks · News reference
Analysts downgraded PJT, OPCH, CRBU, ABEV , cutting price targets for PJT, CRBU.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
PJT Partners is serving as the exclusive financial adviser to Irish Continental Group (ICG) regarding its acquisition by Bluefin Bidco Limited.
A Transportes Imediato, principal operadora logística da Ambev no Brasil, foi condenada pela Justiça devido à prática de jornadas de trabalho exaustivas impostas a seus motoristas.
DelveInsight released a comprehensive competitive landscape report on BCMA-targeted therapies, analyzing 100+ pipeline drugs across 80+ companies. The report highlights recent clinical advances including Pfizer's positive Phase III results for ELREXFIO, AbbVie's BLA submission for etentamig, and Gilead's $7.8 billion acquisition of Arcellx to gain control of anito-cel. Key challenges include treatment resistance, relapse, and manufacturing complexity, while the pipeline focuses on improving durability, safety, and accessibility through next-generation approaches.
Caribou Biosciences reported its financial results for the third quarter of 2026, highlighting a net loss of $26.6 million and ongoing strategic restructuring efforts.
McKesson Corporation and private equity firm Clayton, Dubilier & Rice have engaged Wall Street banks to arrange $3.1 billion in financing for their acquisition of Option Care Health.
Caribou Biosciences announced that clinical abstracts for its vispa-cel and CB-011 programs have been accepted for presentation at the 2026 American Society of Hematology (ASH) Annual Meeting.